Predictive Disease Analytics Market Outlook:
Predictive Disease Analytics Market size was over USD 3.72 billion in 2025 and is projected to reach USD 23.62 billion by 2035, witnessing around 20.3% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of predictive disease analytics is evaluated at USD 4.4 billion.
The market is driven by advanced technologies including AI and ML, and big data analytics in healthcare. These tools enable healthcare providers to predict the onset of diseases, personalized treatment plans, and improve patient outcomes. Rising healthcare costs and the demand for value-based care are also pushing stakeholders to invest in the market to enhance efficiency and reduce unnecessary interventions.
The predictive disease analytics market is expected to grow owing to advancements in genomic data, cloud computing, and the integration of IoT in healthcare. The shift towards personalized medicines and precision healthcare is likely to drive innovation in predictive disease analytics. In July 2024, Evidium announced the development of a healthcare AI platform for health systems, clinicians, insurers, and pharma companies. The development is made in collaboration with Oracle Cloud Infrastructure (OCI) aiming to make AI technology reliable for healthcare organizations worldwide. Such developments are also projected to boost the predictive diseases analytics market globally.
